Australian and New Zealand Living Guideline cholesterol‐lowering therapy for people with chronic kidney disease (CARI Guidelines): Reducing the evidence‐practice gap

Documenti analoghi

• CARI Guidelines Commentary on the KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases
  di: Bhadran Bose, et al.
  Pubblicazione: (2025)
• Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update
  di: Adrian Liew, et al.
  Pubblicazione: (2025)
• The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout
  di: Luke C. Wilson, et al.
  Pubblicazione: (2024)
• Impact of cultural diversity on COVID‐19 vaccination hesitancy in kidney transplant recipients
  di: Rachel Frederick, et al.
  Pubblicazione: (2024)
• Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis
  di: Daniel Hirsch, et al.
  Pubblicazione: (2026)